1. Hepatic fibrosis developing in morbid obesity independent of steatohepatitis: new mechanism or the Rube Goldberg machine?

   • Eric R. Kallwitz

   Editorial 11 March 2012 Pages: 1 - 3

2. Angiogenesis: a phenomenon which aggravates chronic liver disease progression

   • Michał Kukla

   Editorial 26 July 2012 Pages: 4 - 12

   

3. Are we ready to use the hepatitis B surface antigen level to guide peginterferon treatment in HBeAg-negative chronic hepatitis B?

   • Henry Lik Yuen Chan

   Editorial 21 June 2012 Pages: 13 - 15

4. Hepatitis C infection and chronic renal diseases

   • Aline Gonzalez Vigani

   Review Article 15 March 2012 Pages: 16 - 27

   

5. Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments

   • Palak J. Trivedi
   • Sue Cullen

   Review Article 20 March 2012 Pages: 28 - 47

   

6. Adenoviral gene therapy in hepatocellular carcinoma: a review

   • Iván Lyra-González
   • Laura Esther Flores-Fong
   • Juan Armendáriz-Borunda

   Review Article 25 April 2012 Pages: 48 - 58

   

7. Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis

   • Caroline D. M. Witjes
   • Susanna M. van Aalten
   • Jan N. M. IJzermans

   Review Article Open access 12 May 2012 Pages: 59 - 64

   

8. Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease

   • Chan Wah-Kheong
   • Goh Khean-Lee

   Review Article 15 June 2012 Pages: 65 - 71

   

9. The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications

   • Juan Acevedo
   • Aníbal Silva
   • Javier Fernández

   Review Article 14 August 2012 Pages: 72 - 79

   

10. Paradigms in the management of hepatic hydrothorax: past, present, and future

    • Sachin Kumar
    • Shiv Kumar Sarin

    Review Article 25 September 2012 Pages: 80 - 87

    

11. Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients

    • Patrick Marcellin
    • Ferruccio Bonino
    • Maurizia R. Brunetto

    Original Article Open access 23 March 2012 Pages: 88 - 97

    

12. Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay

    • Wai-Kay Seto
    • Yasuhito Tanaka
    • Man-Fung Yuen

    Original Article Open access 13 March 2012 Pages: 98 - 105

    

13. A comparison of clevudine and entecavir for treatment-naïve patients with chronic hepatitis B: results after 2 years of treatment

    • Geum-Youn Gwak
    • Sung June Eo
    • Byung Chul Yoo

    Original Article 24 April 2012 Pages: 106 - 110

    

14. Relevance of interleukin-10RB to chronic hepatitis B virus infection and biological activities of interferon-λ and interleukin-22

    • Okki Cho
    • Jae Youn Cheong
    • Sung Won Cho

    Original Article Open access 14 March 2012 Pages: 111 - 118

    

15. Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B

    • Wai-Kay Seto
    • Danny Ka-Ho Wong
    • Man-Fung Yuen

    Original Article Open access 04 May 2012 Pages: 119 - 126

    

16. Short hairpin RNAs with a 2- or 3-base mismatch inhibit HBV expression and replication in HepG2 cells

    • Xiaoguang Li
    • Yuan Hong
    • Jun Cheng

    Original Article 27 May 2012 Pages: 127 - 133

    

17. Analysis of discordance between transient elastography and liver biopsy for assessing liver fibrosis in chronic hepatitis B virus infection

    • Manoj Kumar
    • Archana Rastogi
    • Shiv K. Sarin

    Original Article 23 June 2012 Pages: 134 - 143

    

18. Response to peginterferon-alpha 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 1

    • Tomoo Miyauchi
    • Tatsuo Kanda
    • Osamu Yokosuka

    Original Article 10 February 2012 Pages: 144 - 152

    

19. Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C

    • Mina Nakagawa
    • Naoya Sakamoto
    • the Ochanomizu-Liver Conference Study Group

    Original Article 21 March 2012 Pages: 153 - 161

    

20. Interferon-associated hepatic steatosis is related to discrepancies in biochemical and virological responses of chronic hepatitis C to IFN-based therapy

    • Chun-Hao Chen
    • Jee-Fu Huang
    • Ming-Lung Yu

    Original Article 07 July 2012 Pages: 162 - 170

    

21. Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients

    • Ching-Sheng Hsu
    • Shih-Jer Hsu
    • Jia-Horng Kao

    Original Article 08 July 2012 Pages: 171 - 179

22. The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study

    • Chung-Feng Huang
    • Jee-Fu Huang
    • Ming-Lung Yu

    Original Article 11 August 2012 Pages: 180 - 187

    

23. Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy

    • Chia-Yang Hsu
    • Yun-Hsuan Lee
    • Shou-Dong Lee

    Original Article 08 January 2012 Pages: 188 - 198

    

24. Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma

    • Zhoujing Zhang
    • Shengxiang Ge
    • Pingguo Liu

    Original Article 07 February 2012 Pages: 199 - 207

    

25. Copy-number variations in hepatoblastoma associate with unique clinical features

    • Jia-Feng Wu
    • Chia-Huei Lee
    • Mei-Hwei Chang

    Original Article 08 February 2012 Pages: 208 - 214

    

26. Up-regulation of dbpA mRNA in hepatocellular carcinoma associated with metabolic syndrome

    • Gulanbar Obulhasim
    • Mahmut Yasen
    • Okio Hino

    Original Article 13 March 2012 Pages: 215 - 225

    

27. A nationwide population-based study shows increasing incidence of cholangiocarcinoma

    • Teng-Yu Lee
    • Jaw-Town Lin
    • Chun-Ying Wu

    Original Article 16 May 2012 Pages: 226 - 232

    

28. Hepatic angiogenesis and fibrosis are common features in morbidly obese patients

    • Monika Ciupińska-Kajor
    • Marek Hartleb
    • Łukasz Liszka

    Original Article Open access 29 November 2011 Pages: 233 - 240

    

29. Short- and long-term clinical outcome after balloon-occluded retrograde transvenous obliteration: is pretreatment portal flow direction a predictive factor?

    • Hidehiro Kamezaki
    • Hitoshi Maruyama
    • Osamu Yokosuka

    Original Article 19 May 2012 Pages: 241 - 247

    

30. Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial

    • Shiv Kumar Sarin
    • Smruti Ranjan Mishra
    • Ashish Kumar

    Original Article 10 March 2012 Pages: 248 - 256

    

31. The effect of systemic antibiotic prophylaxis for cirrhotic patients with peptic ulcer bleeding after endoscopic interventions

    • Shih-Cheng Yang
    • Keng-Liang Wu
    • Seng-Kee Chuah

    Original Article 22 June 2012 Pages: 257 - 267

    

32. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy

    • Manish Kumar Lunia
    • Barjesh Chander Sharma
    • Sanjeev Sachdeva

    Original Article 15 March 2012 Pages: 268 - 273

    

33. Spontaneous bacterial empyema in patients with liver cirrhosis in Upper Egypt: prevalence and causative organisms

    • Hoda A. Makhlouf
    • Khairy Hammam Morsy
    • Mahmoud Khairy

    Original Article 04 May 2012 Pages: 274 - 279

    

34. Obesity, type 2 diabetes, age, and female gender: significant risk factors in the development of alcoholic liver cirrhosis

    • Yoshinori Horie
    • Yoshiyuki Yamagishi
    • Toshifumi Hibi

    Original Article 09 February 2012 Pages: 280 - 285

    

35. Comparative proteomic analysis of human donor tissues during orthotopic liver transplantation: ischemia versus reperfusion

    • Bin Wu
    • HongLi Wu
    • MinQiang Lu

    Original Article 11 February 2012 Pages: 286 - 298